We are live on
!
Find out more
GF
Gabelli Funds Portfolio holdings
AUM
$14.8B
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
(+7.3%)
Cap. Flow
-$36.3M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$28.6M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$21.9M |
| 3 |
SKX
Skechers
SKX
|
+$16.9M |
| 4 |
FARO
Faro Technologies
FARO
|
+$14M |
| 5 |
DNB
Dun & Bradstreet
DNB
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$43M |
| 2 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$20.6M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$18M |
| 4 |
FNA
Paragon 28, Inc.
FNA
|
+$16.8M |
| 5 |
Newmont
NEM
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.94% |
| 2 | Financials | 12.8% |
| 3 | Communication Services | 10.31% |
| 4 | Technology | 10.08% |
| 5 | Utilities | 9.78% |
Similar funds
FCAS
BGC
HIIFS
JFG
CCM
AT
IA
MSV
Gabelli Funds's Q2 2025 Portfolio in Review
As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.
- Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
- Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
- Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
- Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
- Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
- Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
- Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.
Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.